Mireille Cartier

1.9k total citations
17 papers, 826 citations indexed

About

Mireille Cartier is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Mireille Cartier has authored 17 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Epidemiology and 7 papers in Hepatology. Recurrent topics in Mireille Cartier's work include Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (4 papers) and HIV/AIDS drug development and treatment (4 papers). Mireille Cartier is often cited by papers focused on Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (4 papers) and HIV/AIDS drug development and treatment (4 papers). Mireille Cartier collaborates with scholars based in Canada, United States and Germany. Mireille Cartier's co-authors include Jacques Archambault, George Kukolj, Lap‐Chee Tsui, Martin L. Breitman, Michel Liuzzi, Richard C. Bethell, Michael G. Cordingley, Frédéric H. Vaillancourt, Louise Pilote and Michael Dahmus and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Mireille Cartier

16 papers receiving 797 citations

Peers

Mireille Cartier
Louise Thauvette Canada
Brigitte Wiedmann United States
Dorjbal Dorjsuren United States
Muriel Lavie France
Kerstin Jahn‐Hofmann Germany
Nikos Pagratis United States
John R. Fulghum United States
Mirko Brunetti Italy
Tokuichi Kawaguchi Japan
Philip C. Simister United Kingdom
Louise Thauvette Canada
Mireille Cartier
Citations per year, relative to Mireille Cartier Mireille Cartier (= 1×) peers Louise Thauvette

Countries citing papers authored by Mireille Cartier

Since Specialization
Citations

This map shows the geographic impact of Mireille Cartier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mireille Cartier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mireille Cartier more than expected).

Fields of papers citing papers by Mireille Cartier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mireille Cartier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mireille Cartier. The network helps show where Mireille Cartier may publish in the future.

Co-authorship network of co-authors of Mireille Cartier

This figure shows the co-authorship network connecting the top 25 collaborators of Mireille Cartier. A scholar is included among the top collaborators of Mireille Cartier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mireille Cartier. Mireille Cartier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
LaPlante, Steven R., Anil K. Padyana, Pierre Bonneau, et al.. (2014). Integrated Strategies for Identifying Leads That Target the NS3 Helicase of the Hepatitis C Virus. Journal of Medicinal Chemistry. 57(5). 2074–2090. 15 indexed citations
2.
Berger, Kristi L., Ibtissem Triki, Mireille Cartier, et al.. (2013). Baseline Hepatitis C Virus (HCV) NS3 Polymorphisms and Their Impact on Treatment Response in Clinical Studies of the HCV NS3 Protease Inhibitor Faldaprevir. Antimicrobial Agents and Chemotherapy. 58(2). 698–705. 29 indexed citations
3.
Berger, Kristi L., Lisette Lagacé, Ibtissem Triki, et al.. (2013). Viral Resistance in Hepatitis C Virus Genotype 1-Infected Patients Receiving the NS3 Protease Inhibitor Faldaprevir (BI 201335) in a Phase 1b Multiple-Rising-Dose Study. Antimicrobial Agents and Chemotherapy. 57(10). 4928–4936. 13 indexed citations
4.
Vaillancourt, Frédéric H., Martine Brault, Louise Pilote, et al.. (2012). Evaluation of Phosphatidylinositol-4-Kinase IIIα as a Hepatitis C Virus Drug Target. Journal of Virology. 86(21). 11595–11607. 50 indexed citations
5.
Vaillancourt, Frédéric H., Louise Pilote, Mireille Cartier, et al.. (2009). Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication. Virology. 387(1). 5–10. 125 indexed citations
6.
7.
Schumer, Gregg, et al.. (2007). Improved Respirator for Protection Against Exposure to Airborne Viruses. American Journal of Infection Control. 35(5). E36–E37.
8.
Liuzzi, Michel, Stephen W. Mason, Mireille Cartier, et al.. (2005). Inhibitors of Respiratory Syncytial Virus Replication Target Cotranscriptional mRNA Guanylylation by Viral RNA-Dependent RNA Polymerase. Journal of Virology. 79(20). 13105–13115. 95 indexed citations
9.
White, Peter W., Anne‐Marie Faucher, Marie-Josée Massariol, et al.. (2005). Biphenylsulfonacetic Acid Inhibitors of the Human Papillomavirus Type 6 E1 Helicase Inhibit ATP Hydrolysis by an Allosteric Mechanism Involving Tyrosine 486. Antimicrobial Agents and Chemotherapy. 49(12). 4834–4842. 31 indexed citations
10.
Archambault, Jacques, Guohua Pan, Mireille Cartier, et al.. (1998). FCP1, the RAP74-Interacting Subunit of a Human Protein Phosphatase That Dephosphorylates the Carboxyl-terminal Domain of RNA Polymerase IIO. Journal of Biological Chemistry. 273(42). 27593–27601. 128 indexed citations
11.
Archambault, Jacques, Ross Chambers, Michael S. Kobor, et al.. (1997). An essential component of a C-terminal domain phosphatase that interacts with transcription factor IIF in Saccharomyces cerevisiae. Proceedings of the National Academy of Sciences. 94(26). 14300–14305. 128 indexed citations
12.
Cartier, Mireille, Martin L. Breitman, & Lap‐Chee Tsui. (1992). A frameshift mutation in the γE–crystallin gene of the Elo mouse. Nature Genetics. 2(1). 42–45. 69 indexed citations
13.
Cartier, Mireille, Martin L. Breitman, & Lap‐Chee Tsui. (1992). A frameshift mutation in the γE-crystallin gene of the Elo mice. Experimental Eye Research. 55. 15–15. 1 indexed citations
14.
15.
16.
17.
Cartier, Mireille, Jean‐Claude Florent, C. Godard, et al.. (1980). Nosiheptide, a sulfur-containing peptide antibiotic isolated fromStreptomyces actuosus 40037. Cellular and Molecular Life Sciences. 36(4). 414–416. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louise Thauvette Breakdown of academic impact, for papers by Brigitte Wiedmann Breakdown of academic impact, for papers by Dorjbal Dorjsuren Breakdown of academic impact, for papers by Muriel Lavie Breakdown of academic impact, for papers by Kerstin Jahn‐Hofmann Breakdown of academic impact, for papers by Nikos Pagratis Breakdown of academic impact, for papers by John R. Fulghum Breakdown of academic impact, for papers by Mirko Brunetti Breakdown of academic impact, for papers by Tokuichi Kawaguchi Breakdown of academic impact, for papers by Philip C. Simister
Rankless by CCL
2026